Liwei W. Zhou

Xiamen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.

LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.

Journal: Frontiers in genetics
Published: April 12, 2026

Retraction Note: Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma.

Retraction Note: Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma.

Journal: Scientific reports
Published: July 15, 2025

USP25 deubiquitinates cytosolic METTL3 to impede glioma proliferation via an m6A-independent pathway.

USP25 deubiquitinates cytosolic METTL3 to impede glioma proliferation via an m6A-independent pathway.

Journal: iScience
Published: May 29, 2025

Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma.

Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma.

Journal: Scientific reports
Published: May 28, 2024

The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis.

The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis.

Journal: Cell death discovery
Published: February 07, 2024

Hematoma Enlargement After Intracerebral Hemorrhage: A Bibliometric Analysis.

Hematoma Enlargement After Intracerebral Hemorrhage: A Bibliometric Analysis.

Journal: World neurosurgery
Published: August 29, 2023

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.

Journal: Frontiers in medicine
Published: June 22, 2023

Proteomic and metabolomic analyses illustrate the mechanisms of expression of the O6 -methylguanine-DNA methyltransferase gene in glioblastoma.

Proteomic and metabolomic analyses illustrate the mechanisms of expression of the O6 -methylguanine-DNA methyltransferase gene in glioblastoma.

Journal: CNS neuroscience & therapeutics
Published: June 12, 2023

The causal relationship between genetically determined telomere length and meningiomas risk.

The causal relationship between genetically determined telomere length and meningiomas risk.

Journal: Frontiers in neurology
Published: March 04, 2023

Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma.

Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma.

Journal: Investigational new drugs
Published: February 22, 2023

The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest.

The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest.

Journal: Cell death & disease
Published: August 19, 2022

Role of personalized 3D printing in brain protection after decompressive craniectomy

Role of personalized 3D printing in brain protection after decompressive craniectomy

Journal: Zhonghua yi xue za zhi
Published: June 15, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026